A survey conducted by EO Care, Inc., showed that Americans would be more inclined to use cannabis to treat their health conditions if they were guided by a clinician.
1,207 Americans recently partook in a EO Care, Inc., study. The company is “the first clinically guided cannabis health and wellness solution for employers,” (1). Participants in the study needed to be employed, either full-time or part-time, and reside in the US where cannabis is legal in most states for medical or recreational use.
According to EO’s press release (1), the key takeaways from the study are:
“Finding clinical guidance for medicinal cannabis is difficult because most doctors lack the knowledge and retail dispensaries are not equipped to provide medical advice,” said Sean Collins, co-founder and CEO of EO Care (1). “As a result, we have tens of millions of Americans using cannabis for health reasons without guidance on specific product recommendations, dosage amounts, possible drug interactions, or consideration of their health history and other potential health risks. Given that sales of cannabis for health reasons is far higher than most prescription drugs, this is a highly concerning situation for healthcare generally.”
Through EO Care, members are able to gain access to healthcare professionals through their employers that offer the program, who can create a personal cannabis care plan such as, what products to use and at what dose based on the patients’ medical history and needs (1). Through the clinician, they will also be put in contact with a member of local dispensaries who are able to fill the order. The most common conditions patients are seeking care for are chronic conditions. For example, cancer treatment symptoms such as nausea, neuropathic pain, seizure disorders, and Parkinson’s disease (1).
A part of the survey, employee sentiment related to employer cannabis policies was studied (1):
“94 % of Americans live in a state where cannabis is legal in some form,” mentioned Collins (1). “And we know a large percentage of Americans have used cannabis in the past year, so this is definitely impacting employees and health outcomes. With the right medicinal cannabis guidance employers have an opportunity to help their employees, improve health outcomes and be progressive leaders in offering this important benefit that employees will come to expect.”
Reference
Is Cannabis a Solution to the Opioid Crisis?
January 23rd 2025In this research overview, Ruth Fisher, PhD, explores how cannabis has shown promise in helping individuals reduce opioid use, potentially decreasing overdose deaths. Though its impact on chronic pain and opioid reduction remains evident, limitations exist and flaws in methodologies in ecological studies complicate conclusions.